0001225208-20-013488.txt : 20201112
0001225208-20-013488.hdr.sgml : 20201112
20201112183531
ACCESSION NUMBER: 0001225208-20-013488
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201111
FILED AS OF DATE: 20201112
DATE AS OF CHANGE: 20201112
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WANG HUIMIN
CENTRAL INDEX KEY: 0001204553
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15525
FILM NUMBER: 201308487
MAIL ADDRESS:
STREET 1: C/O EDWARDS LIFESCIENCES
STREET 2: ONE EDWARDS WAY
CITY: IRVINE
STATE: CA
ZIP: 92614
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Edwards Lifesciences Corp
CENTRAL INDEX KEY: 0001099800
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
IRS NUMBER: 364316614
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE EDWARDS WAY
CITY: IRVINE
STATE: CA
ZIP: 92614
BUSINESS PHONE: 9492502500
MAIL ADDRESS:
STREET 1: ONE EDWARDS WAY
CITY: IRVINE
STATE: CA
ZIP: 92614
FORMER COMPANY:
FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP.
DATE OF NAME CHANGE: 20090225
FORMER COMPANY:
FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP
DATE OF NAME CHANGE: 20000203
FORMER COMPANY:
FORMER CONFORMED NAME: CVG CONTROLLED INC
DATE OF NAME CHANGE: 19991126
4
1
doc4.xml
X0306
4
2020-11-11
0001099800
Edwards Lifesciences Corp
EW
0001204553
WANG HUIMIN
ONE EDWARDS WAY
IRVINE
CA
92614
1
CVP, Japan & Intercontinental
Common Stock
2020-11-11
4
M
0
11649.0000
13.9800
A
105192.1404
D
Common Stock
2020-11-11
4
S
0
81.0000
81.7600
D
105111.1404
D
Common Stock
2020-11-11
4
S
0
3359.0000
81.7600
D
101752.1404
D
Common Stock
2020-11-11
4
S
0
8290.0000
81.0140
D
93462.1404
D
Employee Stock Option (Right to Acquire)
13.9800
2020-11-11
4
M
0
11649.0000
0.0000
D
2015-05-08
2021-05-07
Common Stock
11649.0000
34959.0000
D
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2020.
This transaction was executed in multiple trades at prices ranging from $80.5850 to $81.5200. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.
Linda J. Park, Attorney-in-Fact
2020-11-12